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Abstract
The World Health Organization (WHO) resolution calling on Member States to work towards achieving universal health coverage (UHC) has increased the need for prioritizing health spending. Such need will soon accelerate as low-and middle-income countries transition from external aid. Countries will have to make difficult decisions on how best to integrate and finance previously donor-funded technologies and health services into their UHC packages in ways that are equitable, and operationally and financially sustainable.
The International Decision Support Initiative (iDSI) is a global network of health, policy and economic expertise which supports countries in making better decisions about how best and how much to spend public money on healthcare. iDSI core partners include Center For Global Development, China National Health Development Research Center, Clinton Health Access Initiative, Health Intervention and Technology Assessment Program, Thailand / National Health Foundation, Imperial College London, Kenya Medical Research Institute, and the Norwegian Institute of Public Health. In May 2019, iDSI convened a roundtable entitled Why . strengthening health systems to make better decisions is a Best Buy
The event brought together members of iDSI, development partners and other organizations working in the areas of evidence-informed priority-setting, resource allocation and purchasing. The roundtable participants identified key challenges and activities that could be undertaken by the broader health technology assessment (HTA) community to further country-led capacity building, as well to foster deeper 
Introduction
The World Health Organization (WHO) resolution calling on Member States to work towards achieving universal health coverage (UHC) has increased the need for prioritizing health spending 1 . Such need will soon accelerate as low-and middle-income countries (LMICs) transition from external aid. By 2022, 24 countries are projected to be in simultaneous transition from external financing 2 . Countries will have to make difficult decisions on how best to integrate and finance previously donorfunded technologies and health services into their UHC packages, including identifying and balancing trade-offs between competing health priorities to ensure that high-quality, affordable access to healthcare is provided to the population in ways that are equitable and operationally and financially sustainable.
But how might priority-setting best be done? Health technology assessment (HTA) is a multi-disciplinary exercise in assessing the clinical and cost-effectiveness of health services and technologies, and their broader impact to inform priority setting, resource allocation and purchasing 3 . The WHO has argued that HTA should be a clear part of the priority-setting process and is an important means through which UHC can be achieved and secured. The WHO defines the scope of technologies which can be evaluated using HTA as "medicines, medical devices, vaccines, procedures and systems" 4 .
The International Decision Support Initiative (iDSI) is a global network of health, policy and economic expertise which supports countries in making better decisions about how best and how much to spend public money on healthcare 5 . Funders of the network include the Bill & Melinda Gates Foundation (BMGF) and the UK Department for International Development (DFID). In May 2019, iDSI convened a roundtable 1 discussion in London, UK, entitled Why strengthening health systems to make better decisions is a Best Buy. The event brought together members of the iDSI network, development partners and other organizations working in the areas of evidence-informed priority-setting, resource allocation and purchasing. Discussions explored the priority-setting challenges that governments in Africa and Asia face and how HTA can be a means of strengthening health systems, why investing in evidence-informed priority-setting is a Best Buy for development partners, and how organizations working in this area could work together to add further value. The roundtable participants identified key challenges and activities that could be undertaken by the broader HTA community to further country-led capacity building for priority setting and HTA, as well to foster deeper collaboration between the community itself.
Why is HTA not yet routinely adopted as a tool for strengthening health systems for UHC? Confusion over definitions and terms A notable challenge to the institutionalization of priority setting and HTA identified in the roundtable discussion was a frequent lack of understanding of the vocabulary of HTA and its method among stakeholders in healthcare decision-making processes. This challenge is not surprising, given the HTA community itself is still struggling with definitions. In 2019, a task group was setup with open consultation of HTA definition, a step forward to resolve this challenge, brought together several organisations working on HTA and the WHO to develop an updated definition that consolidates and simplifies the multiple existing definitions to reflect "current and emerging realities of HTA" 6 . The task group proposed the definition:
• A multidisciplinary process that uses explicit and scientifically robust methods to assess the value of using a health technology at different points in its lifecycle. The process is comparative, systematic, transparent and involves multiple stakeholders. The purpose is to inform health policy and decision-making to promote an efficient, sustainable, equitable and high-quality health system 6 .
Participants of the roundtable noted that conceptualising priority-setting and HTA and explaining such concepts to the wider global health community must go beyond agreeing on the definition. It should include outlining what is included in the scope of HTA, as well as the priority setting process, which may include terms of engagement with stakeholders and the identification of topics for evidence review. HTA should be viewed as more than a merely technocratic exercise. It can at its best be a bridge to join professional technical assessment and professional policy decision-making in a fully integrated whole.
Assessment tools must be designed to address the nature of the decisions that need to be taken and the policy decision making process to ensure critical political elements are taken into account in the tools' design. This becomes much more than a matter of a definition of HTA, for it includes a role for context, scope and process. HTA, then, is both the portfolio of analytical tools for assessment (the "assessment" tools) and the broader range of topics that define context, objectives, barriers, conflicting interests that, taken together, amount to a kind of "political economy" of healthcare prioritization. On this view, while the technical attributes of "assessment", like the meanings of opportunity cost, evidence, effectiveness or model building, are common to all practical applications of HTA, in any specific application, the objectives, the weights attached to them, the scope of costs and outcomes and the historical and cultural context which may make decisions and their implementation more or less possible, are particular to that application. In this sense, "one size does not fit all", there is no universally correct "perspective" of a study and "cost-effectiveness" is a function of local circumstances: what is cost-effective in one place may or may not be cost effective in another. Roundtable participants noted that once consensus is reached in defining HTA, greater efforts must be made to communicate the agreed definition clearly and definitively to relevant stakeholders while concurrently connecting stakeholders to facilitate knowledge and information sharing required as part of such a multidisciplinary endeavour.
The politics of HTA Many countries have struggled with rationing of health services to serve population needs 7 . In the absence of processes and methods for explicit rationing, decision-makers will find it easier to say 'yes' to health technologies including those that are novel and costly-decisions that may be politically favourable in the short run but prove financially unsustainable in the long run-and be reluctant to say 'no', with little consideration of effectiveness or cost-effectiveness. Evidence-informed priority-setting in comparison forces decision makers and their constituents to consider the trade-offs of any decision and helps decision maker justify what healthcare and resources are not to be included. HTA agencies across countries, notably the National Institute for Health and Care Excellence (NICE) in England, have driven up spending and put necessary pressure on health budgets. As such, it was noted in discussions that HTA need not only result in rejections. For example, HTA has been successfully used as a tool to inform price negotiations, procurement of commodities as well as in adjusting healthcare packages (i.e. what is provided to whom and under what circumstances?). It can thus drive governments' and development partners' Best Buys agendas, and such benefits must be more clearly communicated.
Lack of understanding about how policymakers and payers can use HTA LMIC governments and healthcare payers have many needs for capacity and strengthened systems in priority-setting for UHC 8 , and there is a proliferation of global initiatives and organisations providing technical assistance. However, when many different donor-funded organisations are providing technical assistance, often in an uncoordinated manner, this can overwhelm LMIC governments and healthcare payers whose capacities are typically already overstretched 9 . Such disorganisation is exacerbated by the existence of multiple health packages, decision makers, donor funds, and insurance schemes in each country. A clearer narrative around priority setting, HTA and how it can assist governments in achieving UHC is overdue, as is communication between domestic and global organisations working in these areas. The roundtable discussed the need for developing a new publication which might build on discussions in What's In, What's Out: Designing Benefits for Universal Health Coverage 10 , addressing the current issues facing the HTA movement, how to link priority setting to upstream financing and downstream payment, the possible means of engaging with governments and budget holders in practical activities such as procurement. Linking the exercise of HTA to realisable savings was flagged as a priority. We try to offer such examples of practical applications of HTA in Figure 1 .
Country-owned applications of global and local evidence
Another major challenge relates to how traditional academic researchers and organizations whose roles are primarily in providing technical assistance can work together to serve partner LMICs in a responsive, demand-driven manner. For instance, these groups are required to work together in building capacity for the production and use of HTA evidence; and in understanding whether and how international evidence can be applicable locally. International development partners are investing in data collection and synthesis, notably through initiatives like the Disease Control Priories Network (DCPN), funded by BMGF, which promotes and assists in the use of economic evaluation for priority setting at global and country levels. DCPN most recently published Disease Control Priorities, Third Edition, a review of evidence on cost-effective interventions to address the burden of disease in LMICs 11 . However, the next phase of work for DCPN and other organizations in the HTA community, must bring together academics, data and technical assistance together to explore how evidence outputs can be applied in practical, locally-owned priority setting.
Working towards sustainability and cohesion
The roundtable suggested that the WHO could be a "knowledge broker", connecting decision-makers who require evidence or practical support to help them make difficult decisions with those who are in a position to provide such evidence or support. The WHO hosted Decide Health Decision hub, a platform established in June 2019 with the objective of hosting a virtual space to dedicated to supporting collaboration in the field of data-driven health decision making, through HTA, economic evaluation, investment cases or any other process encouraging fair and transparent decision making, could be an ideal platform to enable this 12 . The roundtable endorsed the development of the platform and called for all partners to support the WHO in its coordination efforts. Strong leadership in the development of the HTA movement is crucial to the sustainability of HTA, as is long term financing in government ministries. There is a secondary need to ensure that monitoring and evaluation mechanisms exist to measure and understand success. It was noted that the configuration of global health financing is changing, with an increasing reliance on concessional loans and less on donor funding as aid transition takes effect. As such, governments need to take responsibility for the development of strong and sustainable health systems. They need to recognize and seek out individuals and organizations with the skills to assist where gaps in knowledge and skills exist. In response to these needs, the roundtable endorsed the development of a unified Theory of Change for the major initiatives and organizations working in priority setting and HTA. The article builds up to three recommendations or "next steps" -a publication package to develop and document practice of health technology assessment (HTA), a "call for WHO to redouble its efforts […] to support countries in developing priority setting," and development of a "single Theory of Change." These recommendations follow clearly from the discussion.
There are, however, a number of shortcomings which compromise the effectiveness of the letter: The abstract is inadequate, and reads at first sight like an introduction. (Indeed, it turns out that is has been pasted and rearranged from the introduction.) This should be rewritten to communicate gist of discussions and recommendations.
The perspective -i.e., the dividing line between general remarks or exposition of a topic on one hand, and documentation of roundtable discussion on the other -is not always clear.
In the section on "confusion over definitions and terms" (paragraph starting " Participants of the roundtable noted ..." until end of section) I am puzzled by the contrast between the "professional technical assessment and professional policy decision-making." This, and the following paragraph in which this theme is developed, lacks a clear health systems perspective which would usefully complement and connect the themes developed.
The section on "Theory of Change" appears out of context, because the article here conflates challenges in application of HTA and the perspective of institutions driving the HTA agenda and embedding it in a broader health policy agenda. I propose to separate these perspectives and objectives more clearly.
